MODERNA
LIVE

Serial Number

88929661

Owner

MODERNATX, INC.

Attorney

John Francis Ward

First Use Date

May 30, 2013

Filing Date

May 22, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MODERNA Trademark

Serial Number: 88929661 • Registration: 7279640

MODERNA is a trademark filed by MODERNATX, INC. on May 22, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MODERNATX, INC. (316 trademarks)

320 BENT STREET
CAMBRIDGE, MA 02141

Entity Type: 03

Trademark Details

Filing Date

May 22, 2020

Registration Date

January 16, 2024

First Use Anywhere

May 30, 2013

First Use in Commerce

May 30, 2013

Published for Opposition

September 8, 2020

Goods & Services

medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and infectious disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents

biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, inflammatory disorders, immunoregulatory disorders, metabolic disorders and infectious disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for scientific or research use; chemicals for use in biotherapeutics, and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use

scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 31, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 31, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 31, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 31, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 31, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 22, 2024 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 16, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 13, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 12, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 6, 2023 SUPC
USE AMENDMENT FILED
Nov 1, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 1, 2023 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 30, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 30, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 30, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 30, 2023 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 10, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 10, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 10, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 10, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2023 EXRA
SOU EXTENSION 5 GRANTED
Apr 24, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 24, 2023 AITU
SOU EXTENSION 5 FILED
Apr 18, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 18, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 1, 2022 EXRA
SOU EXTENSION 4 GRANTED
Oct 30, 2022 EX4G
SOU EXTENSION 4 FILED
Oct 30, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 30, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2022 EXRA
SOU EXTENSION 3 GRANTED
May 3, 2022 EX3G
SOU EXTENSION 3 FILED
May 3, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
May 3, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 26, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 26, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 26, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2021 EXRA
SOU EXTENSION 1 GRANTED
Apr 26, 2021 EX1G
SOU EXTENSION 1 FILED
Apr 26, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 26, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 3, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 31, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 31, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 31, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 31, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 31, 2020 CNEA
ASSIGNED TO EXAMINER
Jul 31, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 10, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2020 NWOS
NEW APPLICATION ENTERED
May 26, 2020 NWAP